Kallinich T, Haffner D, Rudolph B, Schindler R, Canaan-Kühl S, Keitzer R, Burmester G R, Roesen-Wolff A, Roesler J
Department of Paediatric Pulmonology and Immunology, Charité Campus Virchow-Klinikum, Universitaetsmedizin Berlin, Germany.
Ann Rheum Dis. 2006 Jul;65(7):958-60. doi: 10.1136/ard.2005.043570. Epub 2005 Nov 24.
Tumour necrosis factor (TNF) receptor associated periodic syndrome (TRAPS) is caused by dominant mutations in the TNFRSF1A gene. In typical cases TRAPS begins early in childhood and is characterised by high and remittent fever over a period of 1-4 weeks or longer, accompanied by systemic and local inflammation.
Patient 1 presented with recurrent episodes of weakness, migrating myalgias, arthralgias, exanthema, and chest pain lasting for 1-4 weeks, but without any fever over an initial period of 4 years at least. Diagnosis of TRAPS was confirmed by the heterozygous mutation Y20H in TNFRSF1A. Patient 2, a 23 year old woman never had any symptoms indicative of TRAPS. Genetic evaluation of all members of her family with a TRAPS index patient disclosed the T50M mutation in TNFRSF1A. A medical check up showed proteinuria, and renal biopsy disclosed AA amyloidosis.
TRAPS associated mutations can induce considerable inflammation that is not necessarily accompanied by fever. Even monosymptomatic severe amyloidosis can occur in these patients. Genetic counselling and appropriate management to prevent or mitigate amyloidosis may be necessary.
肿瘤坏死因子(TNF)受体相关周期性综合征(TRAPS)由TNFRSF1A基因的显性突变引起。典型病例中,TRAPS起病于儿童早期,特征为持续1 - 4周或更长时间的高热和弛张热,伴有全身和局部炎症。
患者1表现为反复发作的乏力、游走性肌痛、关节痛、皮疹和胸痛,持续1 - 4周,但在至少最初4年期间无发热。通过TNFRSF1A基因杂合突变Y20H确诊为TRAPS。患者2,一名23岁女性,从未有任何提示TRAPS的症状。对其家族中一名TRAPS索引患者的所有家庭成员进行基因评估,发现TNFRSF1A基因存在T50M突变。医学检查显示蛋白尿,肾活检显示AA型淀粉样变性。
TRAPS相关突变可引发相当程度的炎症,不一定伴有发热。这些患者甚至可能出现单症状性严重淀粉样变性。可能需要进行遗传咨询和适当管理以预防或减轻淀粉样变性。